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1. Introduction 
Mouse catalase (HzOz : HzOz oxidoreductase 
EC 1.11.1.6) exists as a series of five multiple forms 
which are differentially distributed in the peroxi- 
somes and cytoplasm of liver and kidney cells as 
well as in erythrocytes [l-3] . This situation is in 
direct contrast to that in most mammalian species, 
where the catalases do not exhibit native multiplici- 
ty [4] , and have simple chemical and genetic prop- 
erties. Chemical studies on beef liver catalase for 
example, have shown that the purified enzyme con- 
sists of four identical subunits [S] while other stu- 
dies with acatalasemic humans have shown that a 
single structural gene is responsible for the synthesis 
of the enzyme [6] . These apparently divergent as- 
pects between the properties of mammalian cata- 
lases may be reconciled, however, by recent evidence 
for an epigenetic basis of multiplicity for the five 
multiple forms of catalase [l] , a result which sug- 
gests that the multiple forms are not “isozymes” in 
the recently defined sense of this term [7]. These 
views are supported by the present data which con- 
cern the subcellular and cellular localization of mul- 
tiple forms of catalase from normal and acatalasemic 
mice. 
2. Materials and methods 
The strains of normal (Csa) and acatalasemic (Csb) 
mice previously described by Feinstein et al. [8] 
were used in this study*. The animals were young 
* I am grateful to Dr. R.N. Feinstein and to the Argonne 
National Laboratory for kindly donating breeding stocks 
of these mice. 
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adult female mice between the ages of 6-8 weeks 
and were killed by exsanguination with the blood 
being collected in heparinized tubes. After centrifu- 
gation of the blood ( 1200 g, 10 min), the plasma 
and buffy coat were aspirated and discarded. The 
remaining erythrocytes were washed 3 times with 
isotonic saline and treated with an equal volume of 
50 mM Tris-HCl (pH 7.4). The tissues were excised, 
washed in cold isotonic sucrose solution, homoge- 
nized in 10% sucrose/50 mM Tris-HCI (pH 7.4) 
(livers, 10% w/v; kidneys, 30% w/v), and fractionated 
according to the differential centrifugation proce- 
dure of Hogeboom [9] . The nuclei/whole cell frac- 
tion was discarded, and the resultant supernatant 
centrifuged to yield 3 fractions: large granulest ; 
small granulest ; and the supernatant. The granular 
fractions were sequentially extracted with buffers 
containing 50 mM Tris-HCl (pH 7.4) and a buffered 
solution containing Triton X- 100 (0.2%). All prep- 
arations were treated with 10 mM dithiothreitol and 
centrifuged (100,000 g, 60 min) prior to electro- 
phoresis. 
Catalase activity was determined by a spectro- 
photometric method previously described [l] and 
is expressed in International Units/ml. Protein con- 
centrations were determined using the Biuret method, 
with crystalline bovine serum albumin for standards 
[lOI* 
Supernatant fractions were subjected to zone elec- 
trophoresis on vertical 12% starch gels at 4”, with 
Tris-glycine buffer (30 mM, pH 9.0). A voltage gra- 
dient of 20 V/cm was applied for 16 hr. Following 
7 The large granule fraction consists of mitochondria, lyso- 
somes, and peroxisomes with catalase being localized in the 
latter particles (111 : the small granules contain endo- 
plasmic reticulum and cell membrane. 
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Table 1 
Specific activities of normal and acatalasemic mouse erythro- 
cyte and tissue catalase*. 
Homogenate specific activity** 
(I.U/mg protein) 
Sample Normal strain 
Ksa) 
Acatalasemic 
strain 
(Csb) 
Liver 253 126 
Kidney 85 
Erythrocyte 20 (I”,t 
* Average of 5 separate xperiments with female animals. 
** Nuclei and whole cells removed. 
t Activity undetectable by the technique used. 
Table 2 
Subcellular localization of soluble liver and kidney catalase 
activity in normal (Csa) and acatalasemic (Csb) female mice*. 
Sample Large Small Supernatant 
granule granule catalase 
catalase catalase 
(%) (%) (%) 
Csa liver 49-56 l-3 43-49 
Csb liver 58-66 l-3 33-41 
Csa kidney 31-40 l-4 58-67 
Csb kidney 33-42 l-4 55-61 
* Results expressed as percentage of total soluble catalase ac- 
tivity in homogenate after nuclei and whole cells removed. 
Recovery 80-90%. The ranges of activity indicate the varia- 
tion observed in 5 experiments. 
Table 3 
Comparative solubilization of large granular liver and 
kidney catalase from normal (Csa) and 
acatalasemic (Csb) mice*. 
Sample Aqueous released Detergent released 
catalase activity catalase activity 
(I.U. x 103) (I.U. x 103) 
Csa liver 8-11 14-17 
Csb liver 3-6 14-17 
Csa kidney 0.5-l l-3 
Csb kidney 0.05-0.1 0.1-0.4 
* Results expressed in I.U.‘s total catalase activity (X 103) 
recovered from large granules prepared from 10 ml of 10% 
homogenates. The ranges of activity indicate the variation 
observed in 5 experiments. 
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electrophoresis, the gels were sliced, stained for 
catalase activity and photographed [l] . 
3. Results and discussion 
The specific activities of liver, kidney and erythro- 
cyte catalase from normal and acatalasemic female 
mice are listed in table 1. Acatalasemic mice exhibit 
50-70% of the liver catalase activity and 20-30% 
of kidney catalase activity of the normal strain where- 
as erythrocyte catalase is undetectable in the mutant 
strain. This result confirms previous work by Fein- 
stein et al. [ 121 who have reported that acatalasemic 
mice (Csb strain) resemble acatalasemic humans with 
respect to erythrocyte catalase activity. The mutant 
mice however, exhibit reduced yet significant liver 
and kidney catalase activity whereas acatalasemic 
human tissue contained essentially zero activity. More 
recent studies have shown that catalase from acata- 
1asemiC mice is unstable and exhibits reduced catala- 
tic activity compared to the wild type (Csa) [ 13, 141 
and the difference in residual catalase activity between 
the tissues and erythrocytes of these mutant mice 
may be explained in terms of this fact and their dif- 
ferential localization. Liver catalase has a short half 
life (1?4 days) and is therefore being continually syn- 
thesized and degraded [ 15, 161 thus ensuring a con- 
stant supply of the labile enzyme. Erythrocytes, 
however, lack the necessary protein synthetic appa- 
ratus and would rapidly lose their initial catalase ac- 
tivity. 
Table 2 demonstrates that most of the soluble 
liver and kidney catalase activity is differentially dis- 
tributed between the peroxisomes (large granules) 
and the supernatant fractions in both strains. The 
small granules did not contribute any more than a 
few percent of the total activity. Soluble catalase ac- 
tivity in Csa liver is approximately equally distri- 
buted between the large granules and the supernatant 
whereas in Csb liver, the level of supernatant cata- 
lase is significantly lower than that of the peroxi- 
somes. Soluble kidney catalase from both strains ex- 
hibits a consistently higher level of activity in the 
supernatant fraction. 
In addition to soluble catalase, the peroxisomes 
contained further activity which was solubilized by 
detergent treatment. Table 3 lists the relative quanti- 
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Fig. 1. Starch gel zymogram of liver, kidney and erythrocyte catalase multiple forms from normal (Csa) and c catalasemic (Csb) 
female mice. 1) Csa erythrocyte (5% w/v); 2) Csa liver supernatant (10% w/v); 3) aqueous extract of Csa liver large granules (10% 
w/v); 4) Csa kidney supernatant (20% w/v); 5) aqueous extract of Csa kidney large granules (30% w/v); 6) Csb erythrocyte (50% 
w/v); 7) Csb liver supernatant (25% w/v); 8) aqueous extract of Csb liver Large granules (25% w/v); 9) Csb kidney supernatant 
(50% w/v); 10) aqueous extract of Csb kidney large granules (50% w/v). 
ties of soluble and detergent solubilized catalase ac- 
tivity obtained from liver and kidney granule prep- 
arations. It can be seen that kidney peroxisomes 
from acatalasemic mice contain approx. 10% of the 
catalase activity of normal mice. Liver peroxisomes 
from Csb mice, however, exhibit considerably more 
activity and contain one half of the soluble activity 
and comparable levels of the detergent solubilized 
activity when compared with the normal strain. Con- 
sidered together tables 2 and 3 confirm previous 
studies on the subcellular distribution of mouse tis- 
sue catalase [ 1, 3, 41 and illustrate that acatalasemic 
mice exhibit significant yet reduced levels of liver 
and kidney peroxisomal and cytoplasmic catalase ac- 
tivity. 
Starch gel zymograms of liver, kidney, and ery 
throcyte catalase showing multiple forms from nor- 
mal and acatalasemic mice are shown in fig. 1. Five 
forms are observed in normal mouse liver extracts 
which are differentially distributed between the 
peroxisomal and supernatant fractions. The more 
anodal migrating species (catalases 1 and 2) are ob- 
served in the aqueous peroxisomal extracts (slot 3) 
whereas catalases 2-5 are present in the supernatant 
fraction (slot 2). Catalase 5 activity is observed in 
erythrocyte lysates of Csa mice (slot 1) while both 
kidney peroxisomal and supernatant fractions con- 
tain mostly the faster migrating forms of activity 
(slots 4 and 5). The subcellular and cellular distribu- 
tion of catalase multiple forms from acatalasemic 
mice (Csb) is similar to that of normal mice although 
activities are reduced and the multiple forms are elec- 
trophoretically distinct to those of normal mice. 
Although catalase activity for acatalasemic erythro- 
cytes (slot 6) and kidney peroxisomal extracts (slot 
10) is not apparent in fig. 1, prolonged incubations 
prior to histochemical staining reveal zones of acti- 
vity corresponding to the slowest migrating form in 
slot 7 and the zone in slot 8, respectively. 
Recently, an epigenetic basis of multiplicity for 
mouse liver catalase has been proposed and support- 
ed by evidence indicating interconvertibility of the 
five forms of activity [I]. Since catalase is a tetra- 
mer [5, 171, the presence of two types of subunits, 
one a native subunit (A) and the other a more basic 
epigenetic modification (A’) would allow for such 
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multiplicity: A4, A3A’, A2A2’, AA’3, A’4. The acti- 
vity (tables l-3) and multiplicity (fig. 1) data pre- 
sented demonstrate that acatalasemia in mice effects 
the activity and electrophoretic migration of all of 
the multiple forms of catalase which provides evi- 
dence that a single structural gene is responsible for 
their synthesis and supports a recent proposal [l] 
that mouse catalase multiplicity results from an epi- 
genetic modification of a single type of catalase sub- 
unit. 
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